Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Comprehensively covers the multiplicity and diversity of mechanisms underlying resistance to the currently approved drugs, both tyrosine kinase inhibitors and monoclonal antibodies, that specifically inhibit growth factor receptors playing driver or survival functions in cancerExamines specific targets and the cognate drugsEvaluates molecular modes of innate and evolving resistance
| ISBN: | 9783319679303 |
|---|---|
| Sprache: | Englisch |
| Seitenzahl: | 242 |
| Produktart: | Gebunden |
| Herausgeber: | Elkabets, Moshe Yarden, Yosef |
| Verlag: | Springer International Publishing |
| Veröffentlicht: | 10.04.2018 |
| Schlagworte: | Anti-cancer Kinases Resistance Tyrosine therapeutics |
Yosef Yarden, PhD, is Professor, Department of Biological Regulation, The Weizmann Institute of Science, Israel.